Brain Injury

Brain Image
OXYCYTE™ as
a treatment
for TBI

Defense Medicine

Brain Image
OXYCYTE, Battlefield Injuries, and Purple Heart Injury Laboratories

Topical indications

Brain Image

OXYCYTE™ in Wound Care
and Cosmetic Uses

  • NEWS

  • January 13, 2009 — Oxygen Biotherapeutics, Inc. announced today that the company’s common stock will begin trading on the NASDAQ Capital Market with the opening of trading on Friday, January 15, 2010. The shares will continue to trade under the symbol OXBT. In addition, company chairman and CEO Chris Stern will be in New York to ring the opening bell at the NASDAQ one week later on Friday, January 22.

New video

This new video looks at Oxycyte™ as a potential treatment for Traumatic Brain Injury and Decompression Sickness.

Interview with Chris Stern CEO

Placeholder ImageChairman and CEO Chris Stern talks about the expected duration of the Phase II-b TBI trial in this video.



 

Follow us on Twitter